Global NSAIDs API Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global NSAIDs API Market: By Molecule Type (Ibuprofen, Aspirin, Paracetmol, Diclofenac, and Others), By Formulation (Tablets, Capsules. Suspension, Topical Presentations, and Others), and Geography


$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
$ PRICE - $ 3,000.00$ 8,900.00


Global NSAIDs API Market Report Description:

Global NSAIDs API market report gives comprehensive outlook on NSAIDs API across the globe with special emphasis on North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report on global NSAIDs API market gives historical, current, and future market sizes (US$ Mn) on the molecule type, formulation, and region. This report studies Global NSAIDs API market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Global NSAIDs API market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Global NSAIDs API market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global NSAIDs API market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Global NSAIDs API.


Global NSAIDs API Market:

The global NSAIDs API market estimated to be valued US$ 2,723.2 Mn in 2018 and poised to grow at significant CAGR over 2019-2025 owing to increase in prevalence of arthritis, which is the major cause for the disability and growing number of geriatric population across the globe drives the growth of the market. For instance, According to Center for Disease Control and Prevention (CDC), from 2013-2015, approximately 54.4 Mn US adults had some form of arthritis such as gout, rheumatoid arthritis, fibromyalgia, and lupus and estimated to reach 78 Mn adults aged 18 years older are projected to have arthritis by 2040.  NSAIDs are drug class that groups together drugs that provide analgesic and anti-pyretic effects. Moreover, increasing access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating positive impact on NSAID market.  However, availability of alternative products in the market for NSAIDs and development of advanced medications are expected to hamper the growth of the market.


Ease of Administration and Drugs available at Affordable Prices

Low cost of the non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, piroxicam, aspirin, and other drugs coupled with the better availability of the products boost the revenue growth of global NSAIDs market over the forecast years. Formulation of NSAIDs for the patient convenience also enhance the market revenue in the forthcoming years. For instance, Pfizer, Inc. marketing the Flector (Diclofenac Epolamine Topical Patch) to treat acute pain due to minor strains, sprains, and bruises. In addition, NSAIDs also available in the injectable forms which are easy to administer the patients unable to swallow the tablets. Moreover, Mylan laboratories manufacturing Brufen effervescent granules that can be easily administered for the geriatric and paediatric patients


North America Leads the Market with Highest Share in Global NSAIDs API Market

North America accounted for larger revenue share in global NSAIDs API market with significant CAGR and is expected to grow with highest CAGR during the forecast period owing to high demand for APIs in drug formulations and research and development programs in the region. Moreover, increasing preference towards generic medicine in the region enhances the growth of the market for APIs. Asia Pacific holds second highest share in the global NSAIDs API market due to presence of large number of generic manufacturers and increasing demand for generics in the region drives the market over the forecast period.


Competition Assessment

Key player’s profiles in the global NSAIDs API market include:

  • Granules India Ltd. (India)
  • Xinuha Pharm (China)
  • IOL Chemicals and Pharmaceuticals Ld. (India)
  • Strides Pharma Science Limited (India)
  • SI Group (U.S.)
  • BASF SE (Germany)
  • Bayer AG (Germany)
  • Pfizer, Inc. (U.S.)

Global NSAIDs API market is surging owing to launch of new products in the market to expand their portfolio and their geographical presence. For instance, in November 2017, Sun Pharmaceutical Industries Ltd. BromSite solution, a first NSAID approved by the USFDA for the prevention of ocular pain & treatment of inflammation following cataract surgery. For instance, in March 2019, Teva Pharmaceutical Ltd. announced the launch of an authorized generic of Flector Patch, 1.3%, in the U.S.


Key Findings of the Report:


  • Global NSAIDs API market expanding at significant CAGR over 2018 to 2025 owing to increasing number of generic manufacturers and demand for generic drugs due to rising healthcare costs
  • Based on molecule type, Aspirin accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in Global NSAIDs API market


Key Features of the Report:


  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Detailed Segmentation


By Molecule Type

  • Ibuprofen
  • Aspirin
  • Paracetmol
  • Diclofenac
  • Others

By Formulation

  • Tablets
  • Capsules
  • Suspension
  • Topical Presentations
  • Others



North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA



PBI Location Map


Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084


Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX